Shanghai Medicilon Inc. (SHA:688202)
China flag China · Delayed Price · Currency is CNY
74.22
-5.88 (-7.34%)
Nov 16, 2026, 4:00 PM EST

Shanghai Medicilon Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5351,1631,0381,3661,6591,167
Revenue Growth
42.27%12.08%-24.01%-17.68%42.12%75.28%
Gross Profit
394.29192.5330.04305.74675.36527.76
Operating Income
-26.58-184.78-371.8-84.17322.6308.47
Net Income
-46.14-167.83-330.85-33.21338.24282.22
Earnings Per Share
-0.35-1.27-2.47-0.262.782.32
EPS Growth
----19.75%117.71%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Drug Discovery and Pharmaceutical Research
573.03495.07631.8735.24612.97
Preclinical Study
589.91542.21733.8923.63553.53
Total
1,1631,0371,3661,6591,167

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
516.07567.03700.52990.1197.13512.37
Total Debt
212.93247.44346.08382.88274.943.56
Net Cash (Debt)
303.15319.59354.44607.22-77.76468.8
Net Cash Growth
45.79%-9.83%-41.63%--0.61%
Net Cash Per Share
2.322.422.654.75-0.643.86

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
216.41105.17-22.7533.32-21.33452.94
Capital Expenditures
-173-69.03-110.39-185.68-404.06-292.71
Free Cash Flow
43.4136.14-133.14-152.36-425.39160.22
Free Cash Flow Growth
115.00%----79.93%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
25.69%16.55%2.90%22.39%40.71%45.21%
Operating Margin
-1.73%-15.89%-35.83%-6.16%19.45%26.43%
Pretax Margin
-2.94%-15.91%-36.72%-4.33%22.19%27.66%
Profit Margin
-3.01%-14.43%-31.88%-2.43%20.39%24.18%
FCF Margin
2.83%3.11%-12.83%-11.16%-25.64%13.73%

Dividends

Fiscal Year
FY 2022FY 2021
Period EndingDec '22 Dec '21
Dividend Per Share
0.2790.699
Dividend Per Share Growth
-60.14%117.49%
Dividend Yield
0.18%0.28%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----55.03106.81
Forward PE
-18.7417.1444.40100.83100.83
P/FCF Ratio
224.92205.29---188.15
PS Ratio
6.366.383.896.7411.2225.83